Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
SEPTEMBER 2022LIFE SCIENCES REVIEW6W henever a step toward innovation in the medical field is taken, new and unforeseen risks arise. Game-changing technologies evolve from centuries-old medical practices, bringing with them new competitors. In this regard, regulatory adherence becomes vital to oversee the delivery of healthcare, ensuring public health guidelines are followed, and all patients are offered safe treatment.With the ever-evolving regulatory practices, healthcare businesses have increased the outsourcing of Healthcare regulatory compliance to third parties, in order to focus on crucial aspects such as productivity and objective orientation. With a thorough understanding of the processes as well as providing end-to-end assistance regulatory service providers monitor, these regulatory consultants can help partners control or modify activities within their healthcare organizations to reduce the risk to patients. According to Precedence Research, the global regulatory outsourcing market size is expected to surpass $16.6 billion by 2030 from $6.7 billion in 2022, witnessing growth at a CAGR of 10.2 percent from 2021 to 2030.In this edition of Life Sciences Review Europe, we present the list of the Top 10 Regulatory Services Companies in Europe. We also bring to you thought leadership articles and exclusive insights from expert CIOs and CXOs -Jesper Lekdorf, MD, Sr. Medical Director, Head of Medical Affairs at Novo Nordisk Japan; Caroline Herody, Head of Global Regulatory Affairs at Chr. Hansen, presenting their views and opinions on how organizations can incorporate changes in the regulatory services industry. We hope the valuable insights from industry thought leaders and the regulatory service providers featured in this edition help you make informed decisions for your organization.EDITORIALThe Great Acceleration of Regulatory Services Copyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com September - 04 - 2022, Vol 03, Issue - 04 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comVictor Cruz
< Page 5 | Page 7 >